Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant]

Ítems similars

• Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study
  per: Majeed, Muhammed, et al.
  Publicat: (2016)
• Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study
  per: Majeed, Muhammed, et al.
  Publicat: (2018)
• Oral domperidone: double blind comparison with placebo in irritable bowel syndrome.
  per: Cann, P A, et al.
  Publicat: (1983)
• The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial
  per: Rogha, Mehran, et al.
  Publicat: (2014)
• Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.
  per: Lucey, M R, et al.
  Publicat: (1987)